Genetesis launches CardioFlux membership program to revolutionize preventive cardiac care and eliminate heart disease December 11, 2024 Categories: Health Care Tags: Genetesis
Genetesis: Health Canada approves CardioFlux MCG for the diagnosis of Myocardial Ischemia September 30, 2024 Categories: Health Care Tags: Genetesis
Genetesis formally launches MICRO2 trial with announcement of first patient enrollment July 15, 2024 Categories: Health Care Tags: Genetesis
Genetesis selected for Spoke Membership in ARPA-H Investor Catalyst Hub May 1, 2024 Categories: Health Care Tags: Genetesis
Genetesis announces formal publication of results from the MAGNETO trial April 8, 2024 Categories: Health Care Tags: Genetesis
Genetesis announces new appointments to executive leadership team January 25, 2023 Categories: Health Care Tags: Genetesis
Genetesis announces close of $17.5 million Series C financing October 14, 2022 Categories: Health Care Tags: Genetesis
Genetesis announces two abstracts selected for presentations at upcoming scientific meetings October 21, 2021 Categories: Health Care Tags: Genetesis
